Guglielmi Rinaldo, Mian Caterina, Novizio Roberto, Paoletta Agostino, Persichetti Agnese, Samperi Irene, Scoppola Alessandro, Bagnasco Marcello, De Menis Ernesto, De Rimini Maria Luisa, Raffaelli Marco, Rugiu Maria Gabriella, Andreoli Claudio, Boniardi Marco, Fiorentini Giulia, Locantore Pietro, Papini Enrico, Presciuttini Federica, Rizzati Silvia, Teliti Marsida, Tina Doris, Triggiani Vincenzo, Versari Annibale, Virili Camilla, Vitillo Marina, Basile Michele, Cruciani Fabio, Mitrova Zuzana, Saulle Rosella, Valentini Ilaria, Bartolomei Mirco, Bertino Giulia, Calò Pietro Giorgio, D'Aurizio Federica, Di Cosmo Caterina, Frasoldati Andrea, Marchetti Massimo, Miceli Rosa Elisa, Monti Salvatore, Pontecorvi Alfredo, Rotondi Mario, Attanasio Roberto
Lifenet Health Group, Endocrinology, Regina Apostolorum Hospital, Albano Laziale, RM, Italy.
Endocrinology, Department of Medicine DIMED, University of Padua, Padua, Italy.
J Endocrinol Invest. 2025 Jul 23. doi: 10.1007/s40618-025-02652-y.
The present guideline (GL) is aimed to improve and standardize the treatment of primary hypothyroidism in non-pregnant adults and to offer all the patients the best possible care across the Italian country.
Non-pregnant adults with hypothyroidism.
This GL does not cover the treatment of hypothyroidism in children and adolescents under 18 years of age, in women who are pregnant or breastfeeding, nor in subjects with central hypothyroidism. Also patients who require suppressive therapy with levothyroxine after thyroidectomy for thyroid cancer and those with transient iatrogenic hypothyroidism were not considered in this GL.
The direct costs and the utilization of resources over time were evaluated for the implementation of the appropriate management within the National Health Service. Recommendations were based on the analysis, according to the GRADE methodology, of the evidence from literature. Patients preferences were collected and verified by means of specific bibliographic research and the active participation of two patients' representatives in the GL development group.
The present GL provides 4 formal graded recommendations and 16 ungraded indications for good clinical practice. An elevated agreement was consistently obtained among the panel members.
The present GL provides operative recommendations-based on the best available evidence and cost-effectiveness analysis-for the treatment of adult patients with primary hypothyroidism. The expected benefits from the dissemination, application and implementation of this GL are the improvement of the quality of care, its homogenization across the national territory and the rationalization of health expenditure in the respect of patient preferences.
本指南旨在改善和规范非妊娠成年原发性甲状腺功能减退症的治疗,并为意大利全国所有患者提供尽可能最佳的护理。
非妊娠甲状腺功能减退症成年患者。
本指南不涵盖18岁以下儿童和青少年、孕妇或哺乳期妇女以及中枢性甲状腺功能减退症患者的甲状腺功能减退症治疗。本指南也未考虑甲状腺癌甲状腺切除术后需要左甲状腺素抑制治疗的患者以及短暂性医源性甲状腺功能减退症患者。
评估了在国家卫生服务体系内实施适当管理的直接成本和随时间的资源利用情况。根据GRADE方法,基于对文献证据的分析提出建议。通过特定的文献研究以及两名患者代表积极参与指南制定小组来收集和核实患者偏好。
本指南提供了4条正式分级建议和16条良好临床实践的非分级指征。小组成员之间始终达成了高度一致。
本指南基于现有最佳证据和成本效益分析,为成年原发性甲状腺功能减退症患者的治疗提供了可操作的建议。传播、应用和实施本指南的预期益处是提高护理质量、在全国范围内实现护理同质化以及根据患者偏好合理配置卫生支出。